好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Algorithm-Guided Deep Brain Stimulation Programming Using Automated Motion Sensor-Based Functional Mapping Improves Programming Efficiency
Movement Disorders
P5 - Poster Session 5 (11:45 AM-12:45 PM)
5-005
To quantify the efficiency of wearable sensor-guided programming for DBS.

Deep brain stimulation (DBS) programming can be time intensive and requires extensive experience. Previous pilot studies have demonstrated that motion sensor-based computer-guided DBS programming can significantly improve symptoms with minimal clinician involvement. We carried out a study to evaluate a novel sensor-based functional mapping (SBFM) medical device system for guiding DBS programming.

Eight participants (6 male, 2 female; Age 53-69 years) with recently implanted multiple independent current control DBS systems for treating Parkinson’s disease (PD) were enrolled. The study followed a randomized, cross-over controlled design. Each participant completed two DBS programming sessions: one using standard programming techniques (SoC) and the other with the aid of the SBFM device, which included algorithm-guided programming, motion sensor-based assessment of tremor or bradykinesia, symptom response map visualizations, and automated identification of optimal settings designed to minimize symptom severities, side-effects, and battery usage.

UPDRS-III assessments were performed by a blinded rater before and after each programming session. The time required to program the DBS system, number of settings tested, and final current levels were measured. SoC and SBFM programming were compared using a Wilcoxon signed-rank test.

Total UPDRS-III scores improved significantly for both SBFM (median 43% improvement, p=0.008) and SoC (median 35% improvement, p=0.008) and there was no statistical difference in improvements between SBFM and SoC. SBFM programming significantly reduced the number of settings tested (median 9 vs 31, p=0.047). Median programming time and final current amplitude were both smaller for SBFM (22 minutes vs 39 minutes, 2.0 mA vs. 2.5 mA), but the differences were not statistically significant.

SBFM had similar outcomes to SoC programming but required fewer settings to be tested, which suggests that SBFM could improve programming efficiency and extend expert programming strategies to populations without access to specialized DBS centers.

Authors/Disclosures
Aaron Hadley
PRESENTER
Aaron Hadley has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies.
Vibhor Krishna No disclosure on file
Aristide Merola, MD, PhD (The Ohio State University) Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Rozena Davis, NP (Ohio State University Medical Center) Mrs. Davis has nothing to disclose.
Danielle Englert, MD Dr. Englert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for adamas. Dr. Englert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acadia.
Nicholas J. Fleming, MD (Atrium Neurosciences Institute) Dr. Fleming has nothing to disclose.
Benjamin L. Walter, MD (Cleveland Clinic) Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott.
No disclosure on file
Dustin A. Heldman, PhD (Great Lakes NeuroTechnologies) Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.